Connect with us
The small synthetic biology company “Syngulon” develops technologies based on bacteriocins, natural molecule properties which are of interest to several industrial sectors. It has just signed...
BioNTech is a biotechnology company that is working towards revolutionary new cancer treatment methods. The company is headquartered in the upper city of Mainz and has...
In the biotechnology sector, buyouts and licensing agreements are almost always accompanied by development milestones and other milestone payments. Analysts have attempted to quantify the share...
The Mainz-based company BioNTech develops individualized cancer drugs. The company has raised billions of U.S. dollars on the U.S. technology exchange Nasdaq. BioNtech is a rarity,...
The Liège-based biotech company PDC*line Pharma, which specializes in immuno-oncology, has initiated a Phase I/II study to evaluate a therapeutic vaccine against lung cancer. This cancer...
Immunos Therapeutics, from the Universities of Zurich and Basel, has received new funds from a financing round. On top of that Daniel Vasella, former CEO of...
Regeneron Pharmaceuticals Inc shares rebounded as investors found out about collaboration partner Sanofi SA’s liquidation of its Regeneron stake. The two companies also plan to restructure...
Aiming to attract global advanced biotechnology companies and research institutions, the Incheon City authorities will expand the industrial complex the Songdo Global Biotech Cluster. They are...
The Sartorius Group, a leading international partner of life science research and the biopharmaceutical industry, signed an agreement to acquire a majority stake in the Israeli...
German scientists are calling for an amendment of European genetic engineering law. Their aim is to completely redesign it in the long term. The legal classification...
 |
|
 |  |
 |
|